Eos Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Eos Inc (EOSS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Eos Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 0M vs 129,805M combined for its competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-74.3% annualized vs trailing 12 months), vs holding steady (-1.8%) for its tracked peer group.
- Growth: Eos Inc generated -96.6% revenue growth year over year in Q4 2023, vs 3.5% for its competitors combined.
- Profitability: Its 6,545.7% net margin compares with 15.0% for the peer group.
- Scale: Eos Inc ranks #24 of 27 companies by market capitalization in the Personal & Household Products industry, holding 0.0% of industry market cap.
- Peer revenue share: Eos Inc accounted for 0.0% of combined revenue among its tracked peer group, up from 0.0% a year earlier.
- Peer differentiation: Revenue per employee of $0.00M compares with $0.70M for the peer group (0.0x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
EOSS Sales vs. its Competitors, Q4 2023
Eos Inc reported revenue contraction of 96.59 % year on year in Q4 2023, below its competitors' combined revenue growth of 3.45 %.
With a net margin of 6,545.74 %, Eos Inc achieved higher profitability than its competitors (14.96 %).
Eos Inc generated 0.00 % of the combined sales of its peer group, up from 0.00 % a year earlier.
API endpoints for this dataset
Eos Inc vs. its Competitors, Q4 2023
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Eos Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Eos Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Eos Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (2) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Eos Inc's competitor groups requires a Commercial License.
For context: the Personal & Household Products industry grew revenue 0.7% year over year, combined, vs -96.6% for Eos Inc. Eos Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
Eos Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Eos Inc | Yes | No | No | Yes |
| Competitors combined (15) | ||||
| High-Confidence Competitors (1) | - | |||
| Similar-Size Competitors (5) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
EOSS Stock Performance relative to its Competitors
EOSS Stock Performance relative to High-Confidence Competitors
EOSS Stock Performance relative to Similar-Size Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Helen Of Troy Limited | 282.9% | Outperformed |
| 2 | Arista Networks inc | 282.9% | Outperformed |
| 3 | Est e Lauder Companies Inc | 282.9% | Outperformed |
| 4 | Coty Inc | 282.9% | Outperformed |
| 5 | Procter and Gamble Co | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Eos Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Publicly Traded Peers of Eos Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Eos Inc |
0.06 | 0.12 |
 Procter and Gamble Co |
407,731.54 | 87,922.00 |
 Arista Networks inc |
252,909.58 | 10,540.50 |
 Est e Lauder Companies Inc |
40,922.66 | 15,283.00 |
 The Clorox Company |
13,084.96 | 7,196.00 |
 Coty Inc |
3,601.42 | 5,783.90 |
| SUBTOTAL | 720,129.63 | 135,620.33 |
Sign in to see all competitors of Eos Inc .
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Eos Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Eos Inc's Competitors Named by the Company
Competitive relationships identified from Eos Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Earlyworks Co Ltd | Company report | 85% |
| Dragonfly Energy Holdings Corp | Company report | 85% |
| Ess Tech Inc | Company report | 85% |
| Arista Networks inc | Company report | 85% |
| Energy Vault Holdings Inc | Company report | 85% |
| Est e Lauder Companies Inc | Company report | 85% |
| Avon Products Inc | Company report | 85% |
| Helen Of Troy Limited | Company report | 85% |
| Coty Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Eos Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Eos Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Procter and Gamble Co | Fabric & Home Care 35.25 % |
| The Clorox Company | Health and Wellness 48.19 % |
| Coty Inc | Prestige 64.87 % |
| Helen Of Troy Limited | Home & Outdoor 51.69 % |
| Energy Vault Holdings Inc | Reportable 100.00 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Eos Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Eos Inc | 0 | 887 | 766 |
| Procter and Gamble Co | 407,732 | 845,404 | 154,750 |
| Arista Networks inc | 252,910 | 2,060,704 | 790,733 |
| Est e Lauder Companies Inc | 40,923 | 277,873 | 6,691 |
| The Clorox Company | 13,085 | 817,727 | 78,295 |
| Coty Inc | 3,601 | 510,269 | -48,937 |
| PEERS TOTAL | 720,130 | 695,278 | 96,845 |
Eos Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Eos Inc | Revenue by geography 100.00 % |
| Procter and Gamble Co | Non-US 52.05 % |
| Arista Networks inc | Americas 81.34 % |
| Helen Of Troy Limited | United States 76.17 % |
| Usana Health Sciences Inc | Greater China 49.38 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Eos Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 24 companies in Eos Inc's industry classification, broader than the peer set above. Market cap in millions of $.Eos Inc ranks #24 of 24 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 3,291, indicating a highly concentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Procter and Gamble Co | 410,323 | 53.74 % |
| 2 | Ecolab Inc | 86,881 | 11.38 % |
| 3 | Haleon Plc | 84,079 | 11.01 % |
| 4 | Colgate palmolive Company | 79,154 | 10.37 % |
| 5 | Est e Lauder Companies Inc | 1,234 | 5.2% |
| 6 | Church and Dwight Co Inc | 1,234 | 5.2% |
| 7 | The Clorox Company | 1,234 | 5.2% |
| 8 | E l f Beauty Inc | 1,234 | 5.2% |
| 9 | Interparfums Inc | 1,234 | 5.2% |
| 10 | Coty Inc | 1,234 | 5.2% |
| 24 | Eos Inc | 0 | 0.00 % |
Market cap and industry share for the rest of Eos Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-11.
Eos Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 19 | Cs Diagnostics Corp | 10 | - |
| 20 | Caring Brands Inc | 8 | - |
| 21 | Bonk Inc | 1,234 | 12.3% |
| 22 | Cbdmd Inc | 1,234 | 12.3% |
| 23 | Global Digital Solutions Inc | 1,234 | 12.3% |
| 24 | Eos Inc | 0 | - |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Eos Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-11-12. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Eos Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Personal & Household Products industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (54 companies). See the full Personal & Household Products industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 30.28 % | 38.84 % (avg) | -8.6 pp |
| Operating Margin | - | industry median | - |
| EBITDA Margin | - | 6.85 % (avg) | - |
| Capital Intensity (Capex / Revenue) | 0.63 % | 3.23 % (avg) | -2.6 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Eos Inc's Valuation vs Competitive Position
Valuation multiples vs the Personal & Household Products industry average (54 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Personal & Household Products industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 33.5x | - |
| EV / EBITDA | - | 18.5x | - |
| P/B | -10.0x | 4.4x | -14.4x |
| Return on Equity | - | industry aggregate | - |
| Return on Invested Capital | - | -0.04 % (avg) | - |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Eos Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue Growth | - | - | 20.61 % | -73.71 % | -73.25 % | 25.86 % | -54.51 % |
| Operating Margin | - | 57.02 % | 41.48 % | -253.95 % | - | - | - |
| Return on Invested Capital | -20.70 % | 52.40 % | 23.86 % | -25.47 % | -44.45 % | -149.14 % | - |
| P/E | - | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Eos Inc's BCG Growth-Share Matrix
See Methodology: BCG Growth-Share Matrix for how relative share and growth are calculated and thresholded.
Eos Inc falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 1.7% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution. A caveat worth reading alongside this chart: Procter and Gamble Co alone holds 54% of this industry's market cap. In an industry this dominated by one leader, the framework will place nearly every OTHER company in "Dog" or "Question Mark" purely because relative share is measured against that leader, regardless of how strong those other companies actually are on their own fundamentals. Check the Profitability, Valuation and Financial Strength sections above before treating this quadrant label as a verdict.
Eos Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Low | Industry HHI of 3,291 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 0.63 % vs industry average 3.23 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Eos Inc's dedicated Suppliers and Customers pages, not here.
Eos Inc's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
Eos Inc falls in the Medium attractiveness / Low strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Eos Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Latest-quarter revenue run-rate is decelerating (-74.3% annualized vs trailing 12 months).
- Low relative market share vs the industry leader (0.00x).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
- Industry dominated by Procter and Gamble Co, holding 53.74 % of industry market cap.
Methodology: see Methodology: SWOT Analysis.
Eos Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Eos Inc | 0.02 | 0.24 | - |
| Procter and Gamble Co | 0.26 | 0.71 | 0.71 |
| Arista Networks inc | 0.40 | 3.00 | - |
| Est e Lauder Companies Inc | 0.04 | 1.26 | 1.86 |
| The Clorox Company | 0.16 | 0.74 | 29.06 |
| Coty Inc | 0.10 | 0.78 | 1.56 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Eos Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Eos Inc | Q4 2023 | -76.1 % | - |
| Procter and Gamble Co | Q3 2026 | +4.0 % | -1.0 % |
| Arista Networks inc | Q2 2026 | +37.7 % | +36.5 % |
| Est e Lauder Companies Inc | Q3 2026 | +6.7 % | +395.7 % |
| The Clorox Company | Q3 2026 | +33.3 % | +107.3 % |
| Coty Inc | Q3 2026 | -1.4 % | +48.0 % |
| PEERS TOTAL | +6.8 % | +10.9 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Eos Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Eos Inc | Q4 2023 | -47.8 % | - |
| Procter and Gamble Co | Q3 2026 | +7.3 % | +13.8 % |
| Arista Networks inc | Q2 2026 | +46.9 % | +23.8 % |
| Est e Lauder Companies Inc | Q3 2026 | -2.7 % | -28.1 % |
| The Clorox Company | Q3 2026 | +36.3 % | +5.6 % |
| Coty Inc | Q3 2026 | +1.9 % | -15.2 % |
Eos Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Eos Inc | 24.94% | - | - |
| Procter and Gamble Co | 12.54% | 17.47% | 29.71% |
| Arista Networks inc | 19.52% | 27.21% | 30.78% |
| Est e Lauder Companies Inc | 1.86% | 2.63% | 9.37% |
| The Clorox Company | 9.98% | 15.07% | 551.20% |
| Coty Inc | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Eos Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Eos Inc | - | 0.52 |
| Procter and Gamble Co | 25.62 | 4.64 |
| Arista Networks inc | 62.53 | 23.99 |
| Est e Lauder Companies Inc | 111.78 | 2.68 |
| The Clorox Company | 19.43 | 1.82 |
| Coty Inc | - | 0.62 |
| PEERS AVERAGE | 38.12 | 5.31 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.